Viewing nowCombinationActopin Met Tablet 15/850 mg
Metformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.

MFDS item code 201802737 · Approved 2018.06.29 · Insurance code 661905120
Improvement of glycemic control in patients with type 2 diabetes
This medication is used for helping patients with type 2 diabetes control their blood sugar when combined with diet and exercise. The combination of pioglitazone and metformin contributes to more effective management of blood sugar levels, thereby alleviating symptoms of diabetes.
For the treatment of patients with type 2 diabetes mellitus, the dose of this medicine should be individualized based on efficacy and tolerability, without exceeding the maximum doses of each component: pioglitazone 30mg and metformin 2500mg. The initial dose of this medicine should be based on the patient's current treatment regimen. 1. Patients whose blood glucose is not adequately controlled with metformin or pioglitazone monotherapy: The dose should be based on the current dose of metformin or pioglitazone. Start with 1 tablet of this medicine daily and gradually adjust the dose after evaluating the adequacy of the treatment response. 2. Patients switching from combination therapy with pioglitazone and metformin: Patients switching from combination therapy with pioglitazone and metformin to this medicine may start at their previous doses of pioglitazone and metformin. No studies have been conducted to evaluate the safety and efficacy of switching patients from other oral hypoglycemic agents to this medicine. Any change in treatment for type 2 diabetes mellitus may alter glycemic control; therefore, caution and appropriate monitoring are required. 3. Patients with renal impairment: All dose adjustments should be based on a careful assessment of renal function. In general, older adults, debilitated patients, and malnourished patients should not be titrated to the maximum dose of this medicine. After this medicine is administered to a patient, or when the dose is increased, the patient must be carefully monitored for adverse reactions associated with fluid retention. This medicine should generally be administered in divided doses with meals, which may reduce gastrointestinal adverse reactions caused by metformin. Sufficient time is needed to evaluate the adequacy of the treatment response. Ideally, the response to treatment should be evaluated using glycated hemoglobin (HbA1C), which is a better indicator of long-term glycemic control than fasting plasma glucose (FPG). HbA1c reflects blood glucose levels over the preceding 2 - 3 months. In clinical use of this medicine, if glycemic control measured by FPG has not worsened, administration for an appropriate period (8-12 weeks) is recommended to evaluate changes in HbA1C.
This medication may cause severe lactic acidosis and hypoglycemia, so caution is essential. Lactic acidosis is a rare but potentially fatal condition, with a higher risk in patients with poor kidney function or in those with heart and lung diseases. If dehydration, hypoxia, or signs of sepsis occur during treatment, use of this medication should be discontinued immediately. Patients with impaired liver function should avoid this medication, and alcohol intake should also be avoided. In patients with heart failure, this medication may exacerbate symptoms, so special care is needed if heart failure is present. Patients with severe heart failure, significantly reduced kidney function, or active bladder cancer should not use this medication. Pregnant or breastfeeding women should also avoid this medication. While this medication helps control blood sugar, there may be interactions when taken with other medications, so patients should discuss current medications with their doctor. Elderly patients may have diminished kidney function, necessitating dosage adjustments and regular kidney function tests. Patients should undergo regular blood sugar and blood tests, as well as kidney and liver function tests during treatment, and should inform healthcare providers of any abnormal symptoms. In case of overdose, seek medical attention immediately for appropriate treatment, and if necessary, the drug can be removed through hemodialysis.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. The recommended storage temperature is between 1 to 30 degrees Celsius at room temperature to safely maintain the medication's efficacy.
White to grayish-white oblong film-coated tablet
30 tablets (10 tablets/PTP × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
Pioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Dalim Biotech Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Metformin Hydrochloride · Pioglitazone Hydrochloride
Prescription medication · Combination
Nexpam Korea Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Ilhwa Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.